Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis

Journal of the National Medical Association

Volumn 100, Issue 6, 2008, Pages 716-720

  Gursoy, Alptekin ^a   Tutuncu, Neslihan Bascil ^a   Gencoglu, Arzu ^a   Anil, Cuneyd ^a   Demirer, Asli Nar ^a   Demirag, Nilgun Guvener ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Drugs; Thyroid; Treatment

Indexed keywords

AMIODARONE; GLUCOCORTICOID; LEVOTHYROXINE; PREDNISONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; STEROID; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROID ANTIBODY; THYROTROPIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DOPPLER ECHOGRAPHY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EUTHYROIDISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN SIZE; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; THYROID FUNCTION TEST; THYROID GLAND; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TYPE 2 AMIODARONE INDUCED THYROTOXICOSIS;

EID: 45749145462     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0027-9684(15)31348-1     Document Type: Article

References (27)

1. Wiersinga WM, Trip MD. Amiodarone and thyroid hormone metabolism. Postgrad Med J. 1986;62:909-914.
2. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005;118:706-714.
3. Martino E, Aghini-Lombardi F, Bartalena L, et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med. 1994;154:2722-2726.
4. Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22:240-254.
5. Reichert LJ, de Rooy HA. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ. 1989;298:1547-1548.
6. Trip MD, Duren DR, Wiersinga WM. Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. Br Heart J. 1994;72:266-268.
7. Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2001;86:3-8.
8. Erdogan MF, Gulec S, Tutar E, et al. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Thyroid. 2003;13:205-209.
9. Brennan MD, van Heerden JA, Carney JA. Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management. Surgery. 1987;102:1062-1067.
10. Farwell AP, Abend SL, Huang SK, et al. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA. 1990;263:1526-1528.
11. Hamoir E, Meurisse M, Defechereux T, et al. Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World J Surg. 1998;22:537-542.
12. Houghton SG, Farley DR, Brennan MD, et al. Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. World J Surg. 2004;28:1083-1087.
13. Hermida JS, Tcheng E, Jarry G, et al. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias. Europace. 2004;6:169-174.
14. Iskandar SB, Jordan RM, Peiris AN. Treating amiodarone-induced thyrotoxicosis with radioactive iodine. Tenn Med. 2004;97:408-410.
15. Bogazzi F, Bartalena L, Gasperi M, et al. The various effects of amiodarone on thyroid function. Thyroid. 2001;11:511-519.
16. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8:457-469.
17. Meier DA, Brill DR, Becker DV, et al. Procedure guideline for therapy of thyroid disease with (131)iodine. J Nucl Med. 2002;43:856-861.
18. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101:28-34.
19. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991;91:507-511.
20. O'Sullivan AJ, Lewis M, Diamond T. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol. 2006;154:533-536.
21. Dickstein G, Shechner C, Adawi F, et al. Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med. 1997;102:454-458.
22. Aghini-Lombardi F, Mariotti S, Fosella PV, et al. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest. 1993;16:823-826.
23. Moka D, Dietlein M, Schicha H. Radioiodine therapy and thyrostatic drugs and iodine. Eur J Nucl Med Mol Imaging. 2002;29(suppl 2):486-491.
24. Walter MA, Christ-Crain M, Eckard B, et al. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. Eur J Clin Invest. 2004;34:365-370.
25. Kristoffersen US, Hesse B, Rasmussen AK, et al. Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24 hours radioiodine uptake. Clin Physiol Funct Imaging. 2006;26:167-170.
26. Roti E, Minelli R, Gardini E, et al. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 1992;75:1273-1277.
27. Becker DV, Hurley JR. Complications of radioiodine treatment of hyperthyroidism. Semin Nucl Med. 1971;1:442-460.